Rodman David Malcom
Chief Medical Officer
1 company
Insider Signal Score
56
GoodTrades Analyzed
22
12M Win Rate
30.0%
Avg 3M Return
+2.2%
Avg 12M Return
-49.8%
Rodman David Malcom is a Chief Medical Officer at Mineralys Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $1.5M based on current market prices.
Holdings by Company
MLYSJun 17, 2026
Current Shares57.1K
Value$1.53M
Net Activity-745,403
Bought: 0Sold: 745.4K
Transaction History
Showing 1 filings (page 3)
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | MLYS Mineralys Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 231,716 | $12.92 | $2,994,400.71 | -100% | -42.2% | -14.0% |
← PrevPage 3